Most Clicked StoriesMore >


Exogenous insulin may raise risks in patients with type 2 diabetes

DiabetesPro SmartBrief | Dec 12, 2014

A medical history analysis of 6,484 patients with type 2 diabetes showed those on exogenous insulin therapy had a greater risk of cancer, major adverse cardiovascular events and all-cause death as dosage increased. Researchers said the findings, published in the journal Diabetes, Obesity and Metabolism, indicate a need for further investigation. Healio (free registration) (12/10)


Low blood glucose raises heart, mortality risk in diabetes

DiabetesPro SmartBrief | Dec 16, 2014

White fat cells can be reprogrammed, study finds

DiabetesPro SmartBrief | Dec 16, 2014

Poll: Do you think a glucose-sensing contact lens would be of benefit to your patients?

DiabetesPro SmartBrief | Dec 11, 2014

Diabetes patients show higher cancer incidence in study

DiabetesPro SmartBrief | Dec 16, 2014

Diabetes, obesity patients show lower oxytocin levels

DiabetesPro SmartBrief | Dec 11, 2014

Study: Continued metformin boosts survival in diabetes plus cirrhosis

DiabetesPro SmartBrief | Dec 12, 2014

Experts develop satiety-inducing food ingredient

DiabetesPro SmartBrief | Dec 11, 2014

FDA breakthrough status granted to Lucentis for diabetic retinopathy

DiabetesPro SmartBrief | Dec 17, 2014

Study links flavonoids, healthy aging in women

DiabetesPro SmartBrief | Dec 16, 2014


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


Continuing education for health care professionals who treat patients with diabetes

DiabetesPro SmartBrief | Dec 17, 2014

Consensus Conference on early intervention research in type 1 children

DiabetesPro SmartBrief | Dec 16, 2014

Pre-Conference Workshop: Advocating on Behalf of the Student with Diabetes

DiabetesPro SmartBrief | Dec 16, 2014

ConnecT2Day: Innovative Program Providing Key Insights and Tools for Health Care Professionals

DiabetesPro SmartBrief | Dec 15, 2014

Free CME/CE opportunity: Webcasts from Diabetes is Primary

DiabetesPro SmartBrief | Dec 12, 2014




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


Poll: Do you think a glucose-sensing contact lens would be of benefit to your patients?

Chart.